Autopsy report · NCT03774745

Blocking Mifepristone Action With Progesterone

“Safety”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 6 months before it stopped.
• 12 participants enrolled.
• Results were posted on the registry 5 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 1, Phase 2

Sponsor

University of California, Davis

Sponsor type

University, hospital or other

Conditions

Pregnancy, Unwanted

Interventions

Mifepristone 200 MG; micronized Progesterone; Placebo oral capsule

Participants

12

Sites

3

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.